B4GALNT2 Antikörper (AA 126-175)
Kurzübersicht für B4GALNT2 Antikörper (AA 126-175) (ABIN6750087)
Target
Alle B4GALNT2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
- 
    - 
                                            Bindungsspezifität
- AA 126-175
- 
                                            Spezifität
- Human B4GALNT2
- 
                                            Homologie
- Percent identity by BLAST analysis: Human (100%).
- 
                                            Aufreinigung
- Immunoaffinity purified
- 
                                            Immunogen
- 
                        Synthetic peptide located between aa126-175 of human B4GALNT2 (Q8NHY0, NP_703147). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla (100%), Orangutan, Gibbon, Marmoset (92%), Monkey (85%).
 Type of Immunogen: Synthetic peptide
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- 
                                            Kommentare
- 
                        Target Species of Antibody: Human 
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Rekonstitution
- Distilled water
- 
                                            Konzentration
- Lot specific
- 
                                            Buffer
- Lyophilized from PBS
- 
                                            Lagerung
- 4 °C,-20 °C
- 
                                            Informationen zur Lagerung
- 
                        Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
 Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    
- 
                    
 
                                     
                                     
                                    